Paula M. Hale

Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial

Alan J. Garber, Robert R. Henry, Robert E. Ratner et al. · The Lancet · 2008 · 1K citations

Diabetes Management, Diabetes, Pharmacology +7

Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)

Bernard Zinman, John Gerich, John B. Buse et al. · Diabetes Care · 2009 · 834 citations · Full text

A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity

Aaron S. Kelly, Pernille Auerbach, Margarita Barrientos‐Pérez et al. · New England Journal of Medicine · 2020 · 617 citations · Full text

Liraglutide in Children and Adolescents with Type 2 Diabetes

William V. Tamborlane, Margarita Barrientos‐Pérez, Udi Fainberg et al. · New England Journal of Medicine · 2019 · 333 citations · Full text

Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met + TZD) (Diabetes Care (2009) 32, (1224-1230))

Bernard Zinman, J. E. Gerich, John B. Buse et al. · Diabetes Care · 2010 · 291 citations

Diabetes Management, Medicine, Insulin Management +7